Barbed Sutures for Uterine Prolapse
(BEST Trial)
Trial Summary
What is the purpose of this trial?
Minimally invasive sacrocolpopexy (SCP) performed laparoscopically or with robotic assistance is associated with improved patient-centered outcomes such as faster recovery times, less pain, less bleeding, and shorter hospital stay, however at the expense of longer operating times. One of the time consuming parts of the procedure is vaginal mesh attachment.
Do I have to stop taking my current medications for the trial?
The trial protocol does not specify if you need to stop taking your current medications. However, if you are taking systemic steroids, immunosuppressive, or immunomodulatory treatments, you may not be eligible if taken recently. Please consult with the trial coordinators for more details.
Do I need to stop my current medications for the trial?
The trial protocol does not specify if you need to stop taking your current medications. However, if you are taking systemic steroids or immunosuppressive treatments, you may not be eligible to participate.
What data supports the idea that Barbed Sutures for Uterine Prolapse is an effective treatment?
The available research shows that using barbed sutures for uterine prolapse, specifically in robotic sacrocolpopexy, leads to positive outcomes. One study found that after one year, patients who had this treatment experienced improvements in their condition. Another study compared barbed sutures to non-barbed sutures and found that barbed sutures were effective in securing mesh without increasing the risk of failure. Additionally, barbed sutures resulted in fewer complications, like suture erosion, compared to nonabsorbable sutures. This suggests that barbed sutures are a reliable option for treating uterine prolapse.12345
What data supports the effectiveness of the treatment Barbed Sutures for Uterine Prolapse?
What safety data exists for barbed sutures in uterine prolapse treatment?
The safety data for barbed sutures in uterine prolapse treatment includes studies on robotic sacrocolpopexy (RSC) using barbed delayed absorbable sutures, which evaluated 1-year outcomes. Another study compared the use of delayed absorbable sutures with nonabsorbable ones in robotic sacral colpopexy (RASC), finding that delayed absorbable sutures did not increase the risk of prolapse recurrence and reduced the need for postoperative suture excision. Additionally, a randomized trial compared barbed and non-barbed delayed absorbable sutures for mesh attachment in sacrocolpopexy, providing insights into their efficiency and efficacy.12346
Is it safe to use barbed delayed absorbable sutures in humans?
Research shows that using barbed delayed absorbable sutures in surgeries like sacrocolpopexy (a procedure to correct pelvic organ prolapse) is generally safe. There were fewer complications like suture erosion (when the suture becomes exposed) compared to non-absorbable sutures, and no need for suture removal was reported in the delayed absorbable group.12346
Is the treatment Barbed delayed absorbable suture a promising treatment for uterine prolapse?
How is the barbed delayed absorbable suture treatment for uterine prolapse different from other treatments?
Research Team
Katherine L Woodburn, MD
Principal Investigator
Wake Forest University Health Sciences
Eligibility Criteria
This trial is for English-speaking women over 21 with bothersome vaginal bulge, eligible for laparoscopic or robotic sacrocolpopexy due to uterine prolapse. They must not have poorly controlled diabetes, be unable to maintain certain positions during surgery, or have medical conditions preventing surgery. Women who've had prior mesh repairs or pelvic organ cancer, those on recent steroids/immunosuppressants, and with sensitivity to polypropylene are excluded.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo minimally invasive sacrocolpopexy with either barbed or non-barbed delayed absorbable sutures for vaginal mesh attachment
Follow-up
Participants are monitored for safety, effectiveness, and adverse outcomes, including mesh exposure and quality of life changes
Adverse Outcome Monitoring
Adverse outcomes are assessed and classified according to the Clavien-Dindo system
Treatment Details
Interventions
- Barbed delayed absorbable suture
- Non-barbed delayed absorbable suture
Barbed delayed absorbable suture is already approved in United States, European Union for the following indications:
- Sacrocolpopexy
- Vaginal mesh attachment
- Sacrocolpopexy
- Vaginal mesh attachment
Find a Clinic Near You
Who Is Running the Clinical Trial?
Wake Forest University Health Sciences
Lead Sponsor